Issues
-
The UAE will leave emerging market bond indices next month but its issuers will not suffer much, if at all -
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
-
Investment bank, like the group, wants to diversify outside France, and will lead with its strongest suit, real assets
-
Regular green bond and social bond could come in rest of 2026, but likely no defence bond
-
◆ Japanese insurer had almost no attrition in its senior preferred trade ◆ Some NIP left for investors ◆ Busy week for Japanese issuers in euros
-
Investors are rewarding Romania for trying to fix its fiscal problems
-
◆ AfDB brought forward dollar benchmark ◆ 'Challenges' from tight US Treasury and swap spreads ◆ New Asian investors buying callables
-
Real estate company follows Vinci's €500m five year exchangeable
-
Swiss power company issues only five and seven year floaters
-
◆ Thursday's only covered deal, possibly February's last ◆ French issuer likes dual tranche format ◆ 'Disconnect' between primary and secondary markets apparent, says banker
-
No one is sure when AI's threat will strike, or where
-
◆ French supermarket chain extends curve to 2035 ◆ Deal lands through fair value ◆ SLB volumes slide despite 'flexibility'
